Benzinga | Aug 17, 2021 08:11AM EDT

Sera Prognostics Highlights Publication Of PREVENT-PTB Study In American Journal Of Perinatology

Sera Prognostics Inc., The Pregnancy Company(tm), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the publication, in the American Journal of Perinatology (AJP), https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0041-1732339 of results of the Prediction and Prevention of Preterm Birth (PREVENT-PTB) Study, a prospective, randomized controlled intervention trial conducted between May 2018 through February 2019. The purpose of the trial was to evaluate the impact on neonatal health and economics of applying the company's PreTRM(r) test to screen pregnant women for risk of spontaneous preterm birth (sPTB) and treating the women identified at higher risk with proactive interventions. Trial results showed that using PreTRM(r) to identify and treat those with higher risk pregnancies proactively may lead to better neonatal outcomes.